Skip to content

The Efficacy of Surgical Site Treatment With Ropivacaine in Laparoscopic Surgery

Local Analgesia in Laparoscopic Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02826876
Enrollment
100
Registered
2016-07-11
Start date
2016-07-31
Completion date
2017-07-31
Last updated
2016-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Laparoscopic surgery

Brief summary

Using local analgesia in laparoscopic surgery in order to reduce pain and to reduce the use of narcotic drugs.

Detailed description

At the end of laparoscopic surgery the investigators will spray ropivacaine in the surgical site; and later the investigators will monitor pain intensity and use of analgesic drugs

Interventions

DRUGTopical use

Topical use of Ropivacaine in laparoscopic surgery

intra-operative treatment with ropivacaine Vs placebo in laparoscopic repair of inguinal hernia

OTHERlaparoscopic bariatric surgery

intra-operative treatment with ropivacaine Vs placebo in laparoscopic bariatric surgery

Sponsors

Western Galilee Hospital-Nahariya
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Laparoscopic bariatric surgery * Laparoscopic inguinal hernia surgery

Exclusion criteria

* Cardiac arrythmias * Active ischemic heart disease * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Pain scale as measured by pain scale questionnaire1 Weekpost operative pain intensity will be assisted by VAS(visual analog pain scale) scale at fixed times after surgery

Secondary

MeasureTime frameDescription
Reducing use of narcotics according to nurse records1 Weekpatients will be treated by standard analgetic protocol, the records of analgetic drugs will be collected during patients hospitalization

Countries

Israel

Contacts

Primary ContactMoaad H Farraj, Dr
moaad.farraj@naharia.health.gov.il0507887996

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026